GPCR |
|
no. of analyzed ligands |
range for ΔHo(p,To)
[kJ/mol] |
range for
-TΔSo(p,To)
[kJ/mol] |
ref. |
βRs |
agonists |
13 |
-143 to -17 |
-8 to 93 |
[23] |
antagonists |
15 |
-21 to 16 |
-53 to -16 |
hH1R |
agonists |
14 |
-37.6 to 25.6 |
-59.6 to 5.8 |
[13] |
antagonists |
10 |
-1.5 to 80.2 |
-120.7 to -42.4 |
gpH1R |
agonists |
16 |
-24.1 to 41.8 |
-77.4 to -6.8 |
[13] |
antagonists |
8 |
1.0 to 98.8 |
-145.9 to -49.2 |
gpH3R |
agonists |
7 |
6.4 to 44.5 (buffer A),
-9.2 to 15.1 (buffer ACa) |
-92.0 to -58.3 (buffer A),
-60.7 to -38.1 (buffer ACa) |
[14] |
antagonists |
3 |
-34.1 to -22.9 (buffer A),
-40.7 to -10.5 (buffer ACa) |
-35.1 to -16.9 (buffer A),
-43.8 to -10.3 (buffer ACa) |
D2R |
agonists |
11 |
-224 to 90 |
-136 to 176 |
[23] |
antagonists |
22 |
-89 to 59 |
-105 to 107 |
sheep D2R |
agonists |
1 |
90.0 (high affinity);
54.4 (low affinity) |
-136.0 (high affinity);
-91.1 (low affinity) |
[12] |
antagonists |
3 |
14.6 to 58.6 |
-107.3 to -72.4 |
r5-HT1AR |
agonists |
8 |
-65 to 58 |
-109 to 20 |
[10] |
antagonists |
7 |
15 to 80 |
-109 to -47 |
hCB1R |
agonists |
5 |
17 to 59 |
-108 to -64 |
[21] |
antagonists |
3 |
-52 to -26 |
-11 to 4 |
hCB2R |
agonists |
5 |
27 to 48 |
-89 to -70 |
[21] |
antagonists |
3 |
-19 to -17 |
-22 to -13 |
A1R |
agonists |
6 |
19 to 46 |
-106 to -61 |
[18] |
antagonists |
6 |
-37 to -20 |
-18 to 7 |
A2AR |
agonists |
6 |
7 to 50 |
-83 to -53 |
[18] |
antagonists |
6 |
-45 to -7 |
-28 to -4 |
A2BR |
agonists |
6 |
7 to 23 |
-65 to -37 |
[18] |
antagonists |
6 |
-40 to -20 |
-27 to -3 |
A3R |
agonists |
6 |
21 to 67 |
-122 to -67 |
[18] |
antagonists |
5 |
-52 to -9 |
-24 to -5 |